Indexado en

Licencia y uso

Citaciones

Altmetrics

Análisis de autorías institucional

Compartir

Clinical impact of complex percutaneous coronary intervention in the pre-TAVR workup

Publicado en:Rev Esp Cardiol (Engl Ed). 78 (2): 82-93 - 2025-02-01 78(2), DOI: 10.1016/j.rec.2024.05.002

Autores: Avvedimento, Marisa; Campelo-Parada, Francisco; Nombela-Franco, Luis; Fischer, Quentin; Donaint, Pierre; Serra, Vicenc; Veiga, Gabriela; Gutierrez, Enrique; Franzone, Anna; Vilalta, Victoria; Alperi, Alberto; Regueiro, Ander; Asmarats, Lluis; Ribeiro, Henrique B; Matta, Anthony; Munoz-Garcia, Antonio; Tirado, Gabriela; Urena, Marina; Metz, Damien; Rodenas-Alesina, Eduard; Hernandez, Jose Maria de la Torre; Angellotti, Domenico; Fernandez-Nofrerias, Eduard; Pascual, Isaac; Vidal-Cales, Pablo; Arzamendi, Dabit; Campanha-Borges, Diego Carter; Trinh, Kim Hoang; Nuche, Jorge; Cote, Melanie; Faroux, Laurent; Rodes-Cabaua, Josep

Afiliaciones

Resumen

Introduction and objectives: In patients undergoing percutaneous coronary intervention (PCI) in the workup pre-transcatheter aortic valve replacement (TAVR), the clinical impact of coronary revascularization complexity remains unknown. This study sought to examine the impact of PCI complexity on clinical outcomes after TAVR in patients undergoing PCI in the preprocedural workup. Methods: This was a multicenter study including consecutive patients scheduled for TAVR with concomitant significant coronary artery disease. Complex PCI was defined as having at least 1 of the following features: 3 vessels treated, >= 3 stents implanted,>= 3 lesions treated, bifurcation with 2 stents implanted, total stent length > 60 mm, or chronic total occlusion. The rates of major adverse cardiac events (MACE), including cardiovascular mortality, myocardial infarction, and coronary revascularization were evaluated. Results: A total of 1550 patients were included, of which 454 (29.3%) underwent complex PCI in the preTAVR workup. After a median follow-up period of 2 [1-3] years after TAVR, the incidence of MACE was 9.6 events per 100 patients-years. Complex PCI significantly increased the risk of cardiac death (HR, 1.44; 95%CI, 1.01-2.07), nonperiprocedural myocardial infarction (HR, 1.52; 95%CI, 1.04-2.21), and coronary revascularization (HR, 2.46; 95%CI, 1.44-4.20). In addition, PCI complexity was identified as an independent predictor of MACE after TAVR (HR, 1.31; 95%CI, 1.01-1.71; P = .042). Conclusions: In TAVR candidates with significant coronary artery disease requiring percutaneous treatment, complex revascularization was associated with a higher risk of MACE. The degree of procedural complexity should be considered a strong determinant of prognosis in the PCI-TAVR population. (C) 2024 Sociedad Espanola de Cardiologia. Published by Elsevier Espana, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Palabras clave